The Emily Whitehead Foundation: Connecting Industry to Impact
As long-time partners of Hanson Wade and champions for the CAR-TCR Summit community, the Emily Whitehead Foundation is proud to stand alongside leaders advancing cell and gene therapy. Our mission is to forge personal, lasting connections between patients, families, and the professionals driving these breakthroughs.
Our Vision
Activating the cure so tens of thousands more patients like Emily can become cancer-free
Our Mission
To support patients and caregivers affected by childhood diseases and advocate for all patients who can be treated with advanced therapies
Founded by the family of Emily Whitehead—the first pediatric patient to receive CAR T-cell therapy—the foundation is rooted in advocacy, storytelling, and support for families navigating treatment.
Believe Bundles: Thoughtfully Curated Support for Patients & Families
Make a Direct Impact on the Believe Bundle Program
Every donation supports the delivery of curated care packages to children undergoing treatment. Help us expand this effort to more hospitals and families.
The Emily Whitehead Foundation is a non-profit that raises awareness and funds for childhood cancer research. Aiming to provide funding to researchers to develop innovative and less toxic treatments, such as immunotherapy, for pediatric cancer patients. Co-founders Tom and Kari Whitehead share Emily's story to inspire others to take action in the fight to cure childhood cancer.
Emily Whitehead is a three-time cancer survivor and was the first child in the world to receive CAR-T cell therapy, a form of immunotherapy. Emily is now fourteen years cancer-free and considered cured.
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.